171 related articles for article (PubMed ID: 23453369)
1. MicroRNA-497 is a potential prognostic marker in human cervical cancer and functions as a tumor suppressor by targeting the insulin-like growth factor 1 receptor.
Luo M; Shen D; Zhou X; Chen X; Wang W
Surgery; 2013 Jun; 153(6):836-47. PubMed ID: 23453369
[TBL] [Abstract][Full Text] [Related]
2. Relevance of miR-21 in regulation of tumor suppressor gene PTEN in human cervical cancer cells.
Peralta-Zaragoza O; Deas J; Meneses-Acosta A; De la O-Gómez F; Fernández-Tilapa G; Gómez-Cerón C; Benítez-Boijseauneau O; Burguete-García A; Torres-Poveda K; Bermúdez-Morales VH; Madrid-Marina V; Rodríguez-Dorantes M; Hidalgo-Miranda A; Pérez-Plasencia C
BMC Cancer; 2016 Mar; 16():215. PubMed ID: 26975392
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-362 is downregulated in cervical cancer and inhibits cell proliferation, migration and invasion by directly targeting SIX1.
Shi C; Zhang Z
Oncol Rep; 2017 Jan; 37(1):501-509. PubMed ID: 27878258
[TBL] [Abstract][Full Text] [Related]
4. miR-187 inhibits the growth of cervical cancer cells by targeting FGF9.
Liang H; Luo R; Chen X; Zhao Y; Tan A
Oncol Rep; 2017 Oct; 38(4):1977-1984. PubMed ID: 28849071
[TBL] [Abstract][Full Text] [Related]
5. Dysregulation of hsa-miR-34a and hsa-miR-449a leads to overexpression of PACS-1 and loss of DNA damage response (DDR) in cervical cancer.
Veena MS; Raychaudhuri S; Basak SK; Venkatesan N; Kumar P; Biswas R; Chakrabarti R; Lu J; Su T; Gallagher-Jones M; Morselli M; Fu H; Pellegrini M; Goldstein T; Aladjem MI; Rettig MB; Wilczynski SP; Shin DS; Srivatsan ES
J Biol Chem; 2020 Dec; 295(50):17169-17186. PubMed ID: 33028635
[TBL] [Abstract][Full Text] [Related]
6. Insulin-like growth factor 1 receptor (IGF-1R) as a target of MiR-497 and plasma IGF-1R levels associated with TNM stage of pancreatic cancer.
Xu JW; Wang TX; You L; Zheng LF; Shu H; Zhang TP; Zhao YP
PLoS One; 2014; 9(3):e92847. PubMed ID: 24667580
[TBL] [Abstract][Full Text] [Related]
7. Aberrant expression of oncogenic and tumor-suppressive microRNAs in cervical cancer is required for cancer cell growth.
Wang X; Tang S; Le SY; Lu R; Rader JS; Meyers C; Zheng ZM
PLoS One; 2008 Jul; 3(7):e2557. PubMed ID: 18596939
[TBL] [Abstract][Full Text] [Related]
8. miR-181a Inhibits Cervical Cancer Development via Downregulating GRP78.
Luo C; Qiu J
Oncol Res; 2017 Sep; 25(8):1341-1348. PubMed ID: 28245171
[TBL] [Abstract][Full Text] [Related]
9. miR-212/132 downregulates SMAD2 expression to suppress the G1/S phase transition of the cell cycle and the epithelial to mesenchymal transition in cervical cancer cells.
Zhao JL; Zhang L; Guo X; Wang JH; Zhou W; Liu M; Li X; Tang H
IUBMB Life; 2015 May; 67(5):380-94. PubMed ID: 25988335
[TBL] [Abstract][Full Text] [Related]
10. MiR-21 Regulates Growth and Migration of Cervical Cancer Cells by RECK Signaling Pathway.
Aguilar-Martínez SY; Campos-Viguri GE; Medina-García SE; García-Flores RJ; Deas J; Gómez-Cerón C; Pedroza-Torres A; Bautista-Rodríguez E; Fernández-Tilapa G; Rodríguez-Dorantes M; Pérez-Plasencia C; Peralta-Zaragoza O
Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612895
[TBL] [Abstract][Full Text] [Related]
11. miR-4429 Regulates the Proliferation, Migration, Invasion, and Epithelial-Mesenchymal Transition of Cervical Cancer by Targeting FOXM1.
Liang L; Zheng YW; Wang YL
Cancer Manag Res; 2020; 12():5301-5312. PubMed ID: 32669877
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of miR-30a is associated with proliferation and invasion via targeting MEF2D in cervical cancer.
Zhao J; Li B; Shu C; Ma Y; Gong Y
Oncol Lett; 2017 Dec; 14(6):7437-7442. PubMed ID: 29344185
[TBL] [Abstract][Full Text] [Related]
13. Apoptosis inhibitor-5 overexpression is associated with tumor progression and poor prognosis in patients with cervical cancer.
Cho H; Chung JY; Song KH; Noh KH; Kim BW; Chung EJ; Ylaya K; Kim JH; Kim TW; Hewitt SM; Kim JH
BMC Cancer; 2014 Jul; 14():545. PubMed ID: 25070070
[TBL] [Abstract][Full Text] [Related]
14. ASF1B promotes cervical cancer progression through stabilization of CDK9.
Liu X; Song J; Zhang Y; Wang H; Sun H; Feng X; Hou M; Chen G; Tang Q; Ji M
Cell Death Dis; 2020 Aug; 11(8):705. PubMed ID: 32848135
[TBL] [Abstract][Full Text] [Related]
15. MKRN1 regulates the expression profiles and transcription factor activity in HeLa cells inhibition suppresses cervical cancer cell progression.
Dong X; Zhan Y; Li S; Yang M; Gao Y
Sci Rep; 2024 Mar; 14(1):6129. PubMed ID: 38480859
[TBL] [Abstract][Full Text] [Related]
16. Retracted Article: RNA-sequencing identified miR-3681 as a negative regulator in the proliferation and migration of cervical cancer cells
Shi F; Zhang Y; Wang J; Su J; Liu Z; Wang T
RSC Adv; 2019 Jul; 9(39):22376-22383. PubMed ID: 35519460
[TBL] [Abstract][Full Text] [Related]
17. Potential biomarkers and therapeutic targets in cervical cancer: Insights from the meta-analysis of transcriptomics data within network biomedicine perspective.
Kori M; Yalcin Arga K
PLoS One; 2018; 13(7):e0200717. PubMed ID: 30020984
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of miR-1298 in cervical cancer and its biological function
Zhang H; Zhang R; Zhang G; Liu W; Ma Z; Yue C; Yang M
Oncol Lett; 2021 May; 21(5):401. PubMed ID: 33777224
[TBL] [Abstract][Full Text] [Related]
19. The E6-TAp63β-Dicer feedback loop involves in miR-375 downregulation and epithelial-to-mesenchymal transition in HR-HPV+ cervical cancer cells.
Lu H; Qi Z; Lin L; Ma L; Li L; Zhang H; Feng L; Su Y
Tumour Biol; 2016 Nov; ():. PubMed ID: 27812930
[TBL] [Abstract][Full Text] [Related]
20. HPV16-miRNAs exert oncogenic effects through enhancers in human cervical cancer.
Wang Y; Wang X; Liu Y; He Y; Duan X; Li Q; Huang Y; Xu G; Lu Q
Cancer Cell Int; 2024 May; 24(1):172. PubMed ID: 38750489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
